Efficacy and Safety of Baricitinib in Chinese Rheumatoid Arthritis Patients and the Subgroup Analyses: Results from Study RA-BALANCE

被引：0
|
作者：
Yue Yang
Xing-Fu Li
Xiao Zhang
Chun-De Bao
Jian-Kang Hu
Jian-Hua Xu
Xiang-Pei Li
Jian Xu
Dong-Yi He
Zhi-Jun Li
Guo-Chun Wang
Han-Jun Wu
Fei Ji
Lu-Jing Zhan
Cristiano A. F. Zerbini
Zhan-Guo Li
机构：
[1] Peking University People’s Hospital,
[2] Qilu Hospital of Shandong University,undefined
[3] Guangdong General Hospital,undefined
[4] Renji Hospital Shanghai Jiaotong University School of Medicine,undefined
[5] Jiangxi Pingxiang People’s Hospital,undefined
[6] The First Affiliated Hospital of Anhui Medical University,undefined
[7] The First Affiliated Hospital of USTC (Anhui Provincial Hospital),undefined
[8] Division of Life Sciences and Medicine,undefined
[9] University of Science and Technology of China,undefined
[10] First Affiliated Hospital of Kunming Medical University,undefined
[11] GuangHua Hospital,undefined
[12] First Affiliated Hospital of Bengbu Medical College,undefined
[13] China-Japan Friendship Hospital,undefined
[14] Eli Lilly and Company,undefined
[15] CEPIC-Centro Paulista de Investigação Clinica E Serviços Medicos,undefined
[16] Ipiranga,undefined
来源：
Rheumatology and Therapy | 2020年 / 7卷
关键词：
Arthritis; Baricitinib; China; Rheumatoid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：851 / 866
页数：15
相关论文
共 50 条
  • [1] Efficacy and Safety of Baricitinib in Chinese Rheumatoid Arthritis Patients and the Subgroup Analyses: Results from Study RA-BALANCE
    Yang, Yue
    Li, Xing-Fu
    Zhang, Xiao
    Bao, Chun-De
    Hu, Jian-Kang
    Xu, Jian-Hua
    Li, Xiang-Pei
    Xu, Jian
    He, Dong-Yi
    Li, Zhi-Jun
    Wang, Guo-Chun
    Wu, Han-Jun
    Ji, Fei
    Zhan, Lu-Jing
    Zerbini, Cristiano A. F.
    Li, Zhan-Guo
    RHEUMATOLOGY AND THERAPY, 2020, 7 (04) : 851 - 866
  • [2] Rapid Onset of Efficacy of Baricitinib in Chinese Patients with Moderate to Severe Rheumatoid Arthritis: Results from Study RA-BALANCE
    Li, Zhan-Guo
    Hu, Jian-Kang
    Li, Xiang-Pei
    Yang, Yue
    Li, Xing-Fu
    Xu, Jian-Hua
    Zhang, Xiao
    Xu, Jian
    Bao, Chun-De
    He, Dong-Yi
    Li, Zhi-Jun
    Wang, Guo-Chun
    Zuo, Xiao-Xia
    Liu, Yi
    Xiao, Zheng-Yu
    Chen, Jin-Wei
    Xin, Xia-Fei
    Li, Jing-Yang
    Jiang, Lin-Di
    Liu, Meng-Ru
    Ji, Fei
    Li, Chen-Ge
    ADVANCES IN THERAPY, 2021, 38 (01) : 772 - 781
  • [3] Rapid Onset of Efficacy of Baricitinib in Chinese Patients with Moderate to Severe Rheumatoid Arthritis: Results from Study RA-BALANCE
    Zhan-Guo Li
    Jian-Kang Hu
    Xiang-Pei Li
    Yue Yang
    Xing-Fu Li
    Jian-Hua Xu
    Xiao Zhang
    Jian Xu
    Chun-De Bao
    Dong-Yi He
    Zhi-Jun Li
    Guo-Chun Wang
    Xiao-Xia Zuo
    Yi Liu
    Zheng-Yu Xiao
    Jin-Wei Chen
    Xia-Fei Xin
    Jing-Yang Li
    Lin-Di Jiang
    Meng-Ru Liu
    Fei Ji
    Chen-Ge Li
    Advances in Therapy, 2021, 38 : 772 - 781
  • [4] EFFICACY AND SAFETY OF BARICITINIB IN MTX-IR PATIENTS WITH RHEUMATOID ARTHRITIS: 52 WEEK RESULTS FROM A PHASE 3 STUDY (RA-BALANCE)
    Li, Z.
    Hu, J.
    Bao, C.
    Li, X.
    Li, X.
    Xu, J.
    Spindler, A.
    Zhang, X.
    Xu, J.
    Li, Z.
    Wang, G.
    Sun, J.
    Ji, F.
    Tao, H.
    Zhan, L.
    Rooney, T.
    Zerbini, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 969 - 970
  • [5] Efficacy and safety of baricitinib in Japanese patients with rheumatoid arthritis: Subgroup analyses of four multinational phase 3 randomized trials
    Tanaka, Yoshiya
    Atsumi, Tatsuya
    Amano, Koichi
    Harigai, Masayoshi
    Ishii, Taeko
    Kawaguchi, Osamu
    Rooney, Terence P.
    Akashi, Naotsugu
    Takeuchi, Tsutomu
    MODERN RHEUMATOLOGY, 2018, 28 (04) : 583 - 591
  • [6] EFFICACY AND SAFETY OF BARICITINIB IN JAPANESE RHEUMATOID ARTHRITIS PATIENTS AT 12 WEEKS
    Tanaka, Y.
    Emoto, K.
    Tsujimoto, M.
    Schlichting, D.
    Macias, W.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 231 - 231
  • [7] Safety and Efficacy of Baricitinib in Elderly Patients with Moderate to Severe Rheumatoid Arthritis
    Fleischmann, Roy
    Alam, Jahangir
    Arora, Vipin
    Bradley, John D.
    Schlichting, Douglas E.
    Muram, David
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [8] EFFICACY AND SAFETY OF BARICITINIB (BARI) IN RHEUMATOID ARTHRITIS(RA): CLINICAL AND ULTRASOUND EVALUATION IN REAL LIFE
    Tesei, G.
    Bruni, C.
    Cometi, L.
    Nacci, F.
    Capassoni, M.
    Terenzi, R.
    Tofani, L.
    Bartoli, F.
    Fiori, G.
    Matucci-Cerinic, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1477 - 1478
  • [9] EFFICACY AND SAFETY OF BARICITINIB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO CSDMARDS: SUMMARY RESULTS FROM THE 24-WEEK PHASE III RA-BUILD STUDY
    Emery, Paul
    Krogulec, Marek
    Blanco Alonso, Ricardo
    Rossini, Maurizio
    Raeman, Frank
    Walker, David
    Ghizdavescu, Andrei Petru
    Irto, Ildiko
    Luz Rentero, Maria
    Casillas, Marta
    de la Torre, Inmaculada
    Dougados, Maxime
    RHEUMATOLOGY, 2016, 55 : 60 - 60
  • [10] Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre study
    Guidelli, G. M.
    Viapiana, O.
    Luciano, N.
    De Santis, M.
    Boffini, N.
    Quartuccio, L.
    Birra, D.
    Conticini, E.
    Chimenti, M. S.
    Bazzani, C.
    Bruschi, E.
    Riva, M.
    Canziani, L. M.
    Bianchi, G.
    Pozzi, M. R.
    Limonta, M.
    Gorla, R.
    Perricone, R.
    Frediani, B.
    Moscato, P.
    De Vita, S.
    Dagna, L.
    Rossini, M.
    Selmi, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (04) : 868 - 873
12345